FDA Approved: AVYCAZ — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved a supplemental application for AVYCAZ (ceftazidime-avibactam) from Allergan, Inc., authorizing changes to the approved labeling and indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Intra-abdominal Infection
• Complicated Urinary Tract Infection
• Hospital-acquired Pneumonia
• Ventilator-associated Pneumonia

Drugs mentioned

• Avycaz (ceftazidime-avibactam)

Snippet

SUPPL AP for AVYCAZ (CEFTAZIDIME, AVIBACTAM)